NP
LLY icon

NorthRock Partners’s Eli Lilly LLY Stock Holding History

NorthRock Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.62M Buy
7,201
+518
+8% +$525K 0.11% 105
2025
Q4 		$7.18M Sell
6,683
-8,678
-56% -$8.3M 0.12% 93
2025
Q3 		$11.7M Buy
15,361
+942
+7% +$701K 0.21% 63
2025
Q2 		$11.2M Buy
14,419
+1,098
+8% +$853K 0.29% 46
2025
Q1 		$11M Buy
13,321
+299
+2% +$249K 0.37% 35
2024
Q4 		$10.1M Sell
13,022
-222
-2% -$184K 0.33% 44
2024
Q3 		$11.7M Buy
13,244
+236
+2% +$212K 0.39% 35
2024
Q2 		$11.8M Buy
13,008
+669
+5% +$535K 0.44% 33
2024
Q1 		$9.6M Buy
12,339
+622
+5% +$443K 0.37% 40
2023
Q4 		$6.83M Buy
11,717
+6,543
+126% +$3.82M 0.29% 50
2023
Q3 		$2.78M Buy
5,174
+1,119
+28% +$577K 0.29% 40
2023
Q2 		$1.9M Sell
4,055
-341
-8% -$143K 0.21% 50
2023
Q1 		$1.51M Sell
4,396
-786
-15% -$265K 0.16% 61
2022
Q4 		$1.9M Buy
5,182
+1,043
+25% +$370K 0.22% 49
2022
Q3 		$1.34M Buy
4,139
+217
+6% +$68.8K 0.16% 68
2022
Q2 		$1.27M Buy
3,922
+266
+7% +$79.8K 0.13% 79
2022
Q1 		$1.05M Sell
3,656
-287
-7% -$73.9K 0.09% 97
2021
Q4 		$1.09M Buy
3,943
+1,166
+42% +$296K 0.08% 96
2021
Q3 		$642K Buy
2,777
+524
+23% +$129K 0.05% 131
2021
Q2 		$517K Buy
2,253
+674
+43% +$135K 0.04% 134
2021
Q1 		$295K Buy
1,579
+99
+7% +$19.4K 0.03% 179
2020
Q4 		$250K Sell
1,480
-293
-17% -$43.7K 0.02% 188
2020
Q3 		$262K Buy
1,773
+195
+12% +$30.2K 0.03% 178
2020
Q2 		$259K Sell
1,578
-425
-21% -$65.2K 0.03% 173
2020
Q1 		$278K Sell
2,003
-2,707
-57% -$372K 0.04% 148
2019
Q4 		$619K Buy
+4,710
New +$546K 0.07% 132

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NorthRock Partners's LLY Position: Q1 2026 in Review

NorthRock Partners increased its Eli Lilly (LLY) stake by 7.8% in Q1 2026, buying an estimated $525K and bringing the position to 7,201 shares worth $6.62M. The position accounts for 0.11% of the portfolio, ranked #105.

NorthRock Partners first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $11.8M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NorthRock Partners held 7,201 shares of Eli Lilly worth $6.62M as of Q1 2026.
  • NorthRock Partners bought 518 Eli Lilly shares in Q1 2026, an estimated $525K.
  • Eli Lilly made up 0.11% of NorthRock Partners's portfolio in Q1 2026, its #105 holding.
  • NorthRock Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • NorthRock Partners's Eli Lilly position peaked at $11.8M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.